Tandon Om P, Mehta Ashish K, Halder Sumita, Khanna Naresh, Sharma Krishna K
Departments of Physiology, University College of Medical Sciences, Delhi 110 095.
Indian J Physiol Pharmacol. 2010 Jan-Mar;54(1):21-31.
Both opioid and NMDA receptors have been known to be involved in pain processing in the central nervous system as well as in the periphery. The effect of drugs acting on opioid and NMDA receptors, and their role in modulation of pain response was observed in the formalin model of inflammatory pain in rats. We have demonstrated that morphine has significant antinociceptive effect in the formalin model and this effect was enhanced when given in combination with ketamine. We have also reported modulation of pain response when naloxone or NMDA were co-administered with morphine or ketamine in various combinations. A noteworthy observation in our study is that low dose naloxone when co-administered with ketamine and morphine, or with ketamine and NMDA, caused decrease in the pain response. These observations may suggest that low dose naloxone can cause modulation of opioid and NMDA receptors resulting in antinociceptive effect. Our study thus introduces a new concept of more than two drugs acting on opioid and NMDA receptors to modulate pain response.
众所周知,阿片受体和N-甲基-D-天冬氨酸(NMDA)受体均参与中枢神经系统以及外周的疼痛处理过程。在大鼠炎性疼痛的福尔马林模型中,观察了作用于阿片受体和NMDA受体的药物的效果及其在调节疼痛反应中的作用。我们已经证明,吗啡在福尔马林模型中具有显著的抗伤害感受作用,并且当与氯胺酮联合使用时这种作用会增强。我们还报道了纳洛酮或NMDA与吗啡或氯胺酮以各种组合共同给药时对疼痛反应的调节作用。我们研究中一个值得注意的观察结果是,低剂量纳洛酮与氯胺酮和吗啡联合使用,或与氯胺酮和NMDA联合使用时,会导致疼痛反应降低。这些观察结果可能表明,低剂量纳洛酮可引起阿片受体和NMDA受体的调节,从而产生抗伤害感受作用。因此,我们的研究引入了一种新的概念,即两种以上作用于阿片受体和NMDA受体的药物来调节疼痛反应。